• Explore /
  • Poster
  • / Pharmacokinetic (PK) and pharmacodynamics (PD) properties of SC-PEG <i>e. coli </i>l-asparaginase (EZN-2285) in the treatment of patients with acute lymphoblastic leukemia (ALL): Results from Children's Oncology Group (COG) study AALL07P4.

Pharmacokinetic (PK) and pharmacodynamics (PD) properties of SC-PEG e. coli l-asparaginase (EZN-2285) in the treatment of patients with acute lymphoblastic leukemia (ALL): Results from Children's Oncology Group (COG) study AALL07P4.

Abstract Poster

Authors

null

Anne L. Angiolillo

Children's National Medical Center, Washington, DC

Anne L. Angiolillo , Reuven J. Schore , Gregory H. Reaman , Naomi Joan Winick , Meenakshi Devidas , Hao W. Zheng , Charlotte Wood , Ashley R. Lane , Elizabeth A. Raetz , William L. Carroll , Stephen Hunger

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2012 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Pediatric Oncology

Track

Pediatric Oncology

Sub Track

Leukemia/Lymphoma

Clinical Trial Registration Number

NCT00671034

Citation

J Clin Oncol 30, 2012 (suppl; abstr 9543)

DOI

10.1200/jco.2012.30.15_suppl.9543

Abstract #

9543

Poster Bd #

23

Abstract Disclosures

Similar Posters

First Author: Kelly W. Maloney

First Author: Thomas Lillie

First Author: Arun Azad

First Author: Julio C. Barredo